NR2F1 and endometrial cancer: Furthermore, high NR2F1-AS1 expression has been reported in esophageal squamous cell carcinoma [25], hepatocellular carcinoma [26], endometrial cancer [27], and papillary thyroid carcinoma [28, 29].